Skip to main content
. Author manuscript; available in PMC: 2020 Jul 10.
Published in final edited form as: Ann Surg. 2016 Mar;263(3):582–587. doi: 10.1097/SLA.0000000000001018

TABLE 3.

Treatment and Tumor Burden Characteristics

Characteristic Data
Age at procedure, median (range), yrs 34 (13–68)
Intervention category, n
 Surgery, reoperation 13
 Surgery, first operation 2
 RFA 4
Disease location per patient, n (%)
 Abdominal metastases
  Liver 3 (17.6%)
  Retroperitoneal 14 (82.4%)
 Thoracic metastases 2 (11.8%)
 Bony metastases 6 (35.3%)
No. tumors per disease location, n (range)
 Abdomen 32 (1–6)
 Bone 128 (0–76)
 Thoracic 4 (0–3)
Preoperative pharmacotherapy, n (%)*
 None 2 (10.5%)
 1 drug 3 (15.8%)
 2 drugs 9 (47.4%)
 >3 drugs 5 (26.3%)
Postoperative biochemical response, n (%)
 Partial biochemical response 11 (57.9%)
 Complete biochemical remission§ 6 (31.6%)
*

Drugs included alpha-blockers, beta-blockers, calcium channel blockers, and metyrosine.

Pharmacotherapy refused by a patient.

Partial biochemical response was defined as having at least 1, but not all, biochemical laboratory values returning to the normal range postoperatively.

§

Complete biochemical remission was defined when all indicative laboratory values returned to the normal range postoperatively.